LAB News and Press, Standard BioTools Inc. From 04/22/25

SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report first quarter 2025 financial results on Tuesday, May 6, 2025, after market close. The company will host a conference call and webcast on the same day at 4:...

2025-02-27 12:59:16 ET More on Standard BioTools Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript Standard BioTools Inc. 2024 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Standard BioTools Historical earnings d...

2025-02-27 05:15:09 ET KeyBanc analyst issues SECTOR WEIGHT recommendation for LAB on February 27, 2025 09:36AM ET. The previous analyst recommendation was Overweight. LAB was trading at $1.17 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2025-02-26 21:44:44 ET Standard BioTools Inc. (LAB) Q4 2024 Earnings Conference Call February 26, 2025 04:30 PM ET Company Participants Michael Egholm - President & CEO Alex Kim - Chief Operating Officer & Interim-CFO Conference Call Participants ...

2025-02-26 16:23:20 ET More on Standard BioTools Seeking Alpha’s Quant Rating on Standard BioTools Historical earnings data for Standard BioTools Financial information for Standard BioTools Read the full article on Seeking Alpha For further det...

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the fourth quarter and fiscal year ended December 31, 2024. Recent Highlights: ...

XPEL Inc. (XPEL) is expected to report $0.41 for Q4 2024 MGP Ingredients Inc. (MGPI) is expected to report $1.49 for Q4 2024 Kratos Defense & Security Solutions Inc. (KTOS) is expected to report $0.05 for Q4 2024 Albany International Corporation (AIN) is expected to report $0.65 f...

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report fourth quarter and full year 2024 financial results on Wednesday, February 26, 2025, after market close. The company will host a conference call and webcast on t...

Preliminary, unaudited revenue for the full year 2024 of approximately $174 million Presenting at the 43 rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2024, at 9:45 a.m. PT. SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Standard ...

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company”) announced today that its SomaScan™ Platform played a pivotal role in a study published in the current issue of Nature Medicine titled “Prote...